|
1
|
Arora V and Quinn MA: Endometrial cancer.
Best Pract Res Clin Obstet Gynaecol. 26:311–324. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Harris HR and Terry KL: Polycystic ovary
syndrome and risk of endometrial, ovarian, and breast cancer: A
systematic review. Fertil Res Pract. 2(14)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Raglan O, Kalliala I, Markozannes G,
Cividini S, Gunter MJ, Nautiyal J, Gabra H, Paraskevaidis E,
Martin-Hirsch P, Tsilidis KK and Kyrgiou M: Risk factors for
endometrial cancer: An umbrella review of the literature. Int J
Cancer. 145:1719–1730. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Colombo N, Preti E, Landoni F, Carinelli
S, Colombo A, Marini C and Sessa C: ESMO Guidelines Working Group.
Endometrial cancer: ESMO clinical practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 24 (Suppl
6):vi35–vi39. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yeramian A, Moreno-Bueno G, Dolcet X,
Catasus L, Abal M, Colas E, Reventos J, Palacios J, Prat J and
Matias-Guiu X: Endometrial carcinoma: Molecular alterations
involved in tumor development and progression. Oncogene.
32:403–413. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Amant F, Moerman P, Neven P, Timmerman D,
Van Limbergen E and Vergote I: Endometrial cancer. Lancet.
366:491–505. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Porporato PE, Payen VL, Baselet B and
Sonveaux P: Metabolic changes associated with tumor metastasis,
part 2: Mitochondria, lipid and amino acid metabolism. Cell Mol
Life Sci. 73:1349–1363. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
DeBerardinis RJ and Chandel NS:
Fundamentals of cancer metabolism. Sci Adv.
2(e1600200)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hjerpe E, Egyhazi Brage S, Carlson J,
Frostvik Stolt M, Schedvins K, Johansson H, Shoshan M and
Avall-Lundqvist E: Metabolic markers GAPDH, PKM2, ATP5B and
BEC-index in advanced serous ovarian cancer. BMC Clin Pathol.
13(30)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Guaragnella N, Giannattasio S and Moro L:
Mitochondrial dysfunction in cancer chemoresistance. Biochem
Pharmacol. 92:62–72. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guerra F, Arbini AA and Moro L:
Mitochondria and cancer chemoresistance. Biochim Biophys Acta
Bioenerg. 1858:686–699. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Porporato PE, Payen VL, Perez-Escuredo J,
De Saedeleer CJ, Danhier P, Copetti T, Dhup S, Tardy M, Vazeille T,
Bouzin C, et al: A mitochondrial switch promotes tumor metastasis.
Cell Rep. 8:754–766. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Villena JA: New insights into PGC-1
coactivators: Redefining their role in the regulation of
mitochondrial function and beyond. FEBS J. 282:647–672.
2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gabrielson M, Bjorklund M, Carlson J and
Shoshan M: Expression of mitochondrial regulators PGC1α and TFAM as
putative markers of subtype and chemoresistance in epithelial
ovarian carcinoma. PLoS One. 9(e107109)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Guerra F, Kurelac I, Cormio A, Zuntini R,
Amato LB, Ceccarelli C, Santini D, Cormio G, Fracasso F, Selvaggi
L, et al: Placing mitochondrial DNA mutations within the
progression model of type I endometrial carcinoma. Hum Mol Genet.
20:2394–2405. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cormio A, Guerra F, Cormio G, Pesce V,
Fracasso F, Loizzi V, Cantatore P, Selvaggi L and Gadaleta MN: The
PGC-1alpha-dependent pathway of mitochondrial biogenesis is
upregulated in type I endometrial cancer. Biochem Biophys Res
Commun. 390:1182–1185. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mastropasqua F, Girolimetti G and Shoshan
M: PGC1α: Friend or Foe in. cancer? Genes (Basel).
9(48)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shoshan-Barmatz V and De S: Mitochondrial
VDAC, the Na+/Ca2+ Exchanger, and the
Ca2+ Uniporter in Ca2+ dynamics and
signaling. Adv Exp Med Biol. 981:323–347. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shoshan-Barmatz V and Mizrachi D: VDAC1:
From structure to cancer therapy. Front Oncol.
2(164)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shoshan-Barmatz V and Ben-Hail D: VDAC, a
multi-functional mitochondrial protein as a pharmacological target.
Mitochondrion. 12:24–34. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(review). Mol Med Rep. 11:1566–1572. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Teicher BA, Linehan WM and Helman LJ:
Targeting cancer metabolism. Clin Cancer Res. 18:5537–5545.
2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Salvesen HB, Iversen OE and Akslen LA:
Identification of high-risk patients by assessment of nuclear Ki-67
expression in a prospective study of endometrial carcinomas. Clin
Cancer Res. 4:2779–2785. 1998.PubMed/NCBI
|
|
24
|
Cormio A, Cormio G, Musicco C, Sardanelli
AM, Gasparre G and Gadaleta MN: Mitochondrial changes in
endometrial carcinoma: Possible role in tumor diagnosis and
prognosis (review). Oncol Rep. 33:1011–1018. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ren Z, Yang H, Wang C and Ma X: The
effects of PGC-1α on the proliferation and energy metabolism of
malignant endometrial cancer cells. Onco Targets Ther. 8:769–774.
2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Feilchenfeldt J, Brundler MA, Soravia C,
Totsch M and Meier CA: Peroxisome proliferator-activated receptors
(PPARs) and associated transcription factors in colon cancer:
Reduced expression of PPARgamma-coactivator 1 (PGC-1). Cancer Lett.
203:25–33. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Watkins G, Douglas-Jones A, Mansel RE and
Jiang WG: The localisation and reduction of nuclear staining of
PPARgamma and PGC-1 in human breast cancer. Oncol Rep. 12:483–488.
2004.PubMed/NCBI
|
|
28
|
Luo C, Lim JH, Lee Y, Granter SR, Thomas
A, Vazquez F, Widlund HR and Puigserver P: A PGC1α-mediated
transcriptional axis suppresses melanoma metastasis. Nature.
537:422–426. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shoshan-Barmatz V, Ben-Hail D, Admoni L,
Krelin Y and Tripathi SS: The mitochondrial voltage-dependent anion
channel 1 in tumor cells. Biochim Biophys Acta. 1848:2547–2575.
2015.PubMed/NCBI View Article : Google Scholar
|
